Generics Industry Pushes Congress On Brand-Name Samples
The generic-drug industry advised lawmakers reconciling two versions of the U.S. Food and Drug Administration user fee bills to adopt Senate language that would side with generics makers in a fight...To view the full article, register now.
Already a subscriber? Click here to view full article